Removing MAC is technically challenging, but it offers the best chance for optimal sizing and seating of a prosthetic valve for patients undergoing mitral valve replacement. Our experts share technical advice.
Despite lack of labeling or much safety data, use of DOACs following surgical heart valve replacement is not insignificant — and is growing. So finds a new national cohort study.
Experts advise on developments to look for in the transcatheter space when it comes to managing diseases of the mitral, tricuspid and pulmonary valves.
As use of bioprosthetic mitral valves grows among ever-younger patients, more and more bioprostheses will fail. A new study gives guidance on selecting patients for evolving transcatheter valve-in-valve treatment options.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The 2014 study report that gave an edge to valve replacement over repair for severe ischemic mitral regurgitation appears to have impacted real-world practice, a new analysis shows.
In the setting of prior mitral valve replacement, the challenge of repairing left ventricular outflow tract obstruction lies in widening the outflow tract without removing the prosthetic valve.
A multicenter trial finds high and unpredictable rates of recurrent leakage among mitral valve repair recipients, establishing replacement as the new standard of care for severe ischemic disease.